ethyl 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-Methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate

ethyl 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-Methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate Struktur
1048972-30-0
CAS-Nr.
1048972-30-0
Englisch Name:
ethyl 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-Methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
Synonyma:
ethyl 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-Methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate;Ethyl 1-cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylate;3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-(3-methyl-1-piperazinyl)-4-oxo-, ethyl ester
CBNumber:
CB42574567
Summenformel:
C20H24FN3O4
Molgewicht:
389.42
MOL-Datei:
1048972-30-0.mol

ethyl 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-Methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate Eigenschaften

Siedepunkt:
589.8±50.0 °C(Predicted)
Dichte
1.356±0.06 g/cm3(Predicted)
pka
6.59±0.20(Predicted)

Sicherheit

ethyl 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-Methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

ethyl 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-Methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


ethyl 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-Methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate

  • ethyl 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-Methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
  • 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-(3-methyl-1-piperazinyl)-4-oxo-, ethyl ester
  • Ethyl 1-cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylate
  • 1048972-30-0
Copyright 2019 © ChemicalBook. All rights reserved